Published in Drug Week, March 10th, 2006
This compares to revenues of $1.0 million and a net loss of $6.4 million, or $0.12 per share, for the same period last year. For the first half of the 2006 fiscal year, the company reported revenues of $0.9 million and a net loss of $17.4 million, or $0.32 per share. This compares to revenue of $2.1 million and a net loss of $10.6 million, or $0.20 per share, for the same period last year. The increase in net...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.